-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Jounce Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2018 to 2022.
- Jounce Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2022 was 51.7M shares, a 3.5% increase year-over-year.
- Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 51.7M shares, a 3.5% increase from 2021.
- Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 49.9M shares, a 40.9% increase from 2020.
- Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 35.4M shares, a 3.3% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)